Modulim Receives 3-year Renewal of ISO-13485 Certification
Irvine, CA—January 7, 2024— Modulim received a three-year renewal of their ISO:13485 certification after a comprehensive review of the company’s quality system, which covers capabilities such as design, manufacturing, and customer management. “Receiving a 3-year renewal highlights the robustness of Modulim’s quality system, and the ability of the team to maintain and scale our processes,” […]
Modulim Granted Patent for a System and Method to Assess Diabetic Circulatory Complications
Irvine, CA—September 22, 2023— Modulim, the leader in point of care microvascular insights, announced the grant of United States Patent US11751769B2, titled “Systems and Methods for Assessing Diabetic Circulatory Complications.” This patent signifies a milestone for Modulim and the relevance of its solutions for diabetes patient management. The patent teaches Modulim’s novel approach to assess […]
New Research Published in the Journal of Surgical Case Reports: “Assessment of Revascularization Impact on Microvascular Oxygenation and Perfusion Using Spatial Frequency Domain Imaging”
Irvine, CA—July 15, 2023— A new clinical case study was published in the Journal of Surgical Case Reports. This research, titled “Assessment of Revascularization Impact on Microvascular Oxygenation and Perfusion Using Spatial Frequency Domain Imaging (SFDI),” sheds light on the potential role of microvascular assessment in lower limb interventional procedures. The study presents representative clinical […]
Modulim Receives US Army Contract to Develop Cutting-Edge Handheld Digital Burn Assessment Tool
Irvine, CA—May 18, 2023— Modulim, the leader in point-of-care microvascular insights, was awarded a 2 year, $2.5M contract from the United States Army Medical Materiel Development Activity (USAMMDA) for the development of a handheld digital burn assessment tool. The proposed solution aims to change the way burn injuries are evaluated and managed, with significant implications […]
New Research Published in the Journal of Diabetes Science and Technology Demonstrates the Ability of Spatial Frequency Domain Imaging (SFDI) to Stratify Severity of Microvascular Disease.
Irvine, CA—February 6, 2023— February 6, 2023 A new peer-reviewed article about Modulim’s technology was recently published in the Journal of Diabetes Science and Technology. The article, entitled “Stratification of Microvascular Disease Severity in the Foot using Spatial Frequency Domain Imaging (SFDI),” was a collaboration between researchers at the University of Arizona and Modulim. The […]
News
News Get in touch!
LAMP Solution Video
LAMP Solution Video https://modulim.com/wp-content/uploads/2022/09/Modulim_LAMP_Solution_Video.mp4 Get in touch!
Trademarks
TRADEMARKS Modulim, Clarifi, Ox-Imager CS, and Reflect RS are trademarks or registered trademarks of Modulim. No license, right or permission is granted to you for any use of this trademark by you or anyone authorized by you. All other registered (or unregistered) trade names, trademarks and/or logos are the property of their respective owners.
Terms
TERMS OF USE By accessing, browsing and/or using this web site (“Site”), you acknowledge that you have read, understood, and agree, to be bound by these terms and to comply with all applicable laws and regulations, including U.S. export and re-export control laws and regulations. If you do not agree to these terms, do not […]
Modulim Announces Intent to Drive Value-Based Care in Nephrology Market With Custom Limb Preservation Solution
Irvine, CA—July 6, 2022— Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announced today that it has launched its Limb Assessment, Management, & Preservation (LAMP) solution to enable accountable care organizations to achieve better outcomes for high-risk Chronic Kidney Disease (CKD) and End-Stage Renal Disease […]